Related Experiment Videos
Penicillin-binding proteins of gram-negative bacteria
1Microbial Genetics Group, School of Biological Sciences, University of Sussex, Brighton, United Kingdom.
Reviews of Infectious Diseases
|July 1, 1988
Summary
Beta-lactam antibiotics target bacterial cell wall synthesis by inactivating penicillin-binding proteins (PBPs). Evolutionary links between PBPs and beta-lactamases are supported by structural similarities, explaining antibiotic resistance mechanisms.
Area of Science:
- Microbiology
- Biochemistry
- Evolutionary Biology
Background:
- Beta-lactam antibiotics are crucial antibacterial agents targeting bacterial cell wall synthesis.
- Penicillin-binding proteins (PBPs) are essential enzymes in peptidoglycan biosynthesis, the target of beta-lactams.
- Evidence suggests a distant evolutionary relationship between PBPs and beta-lactamase enzymes.
Purpose of the Study:
- To explore the evolutionary origins and structural relationships between PBPs and beta-lactamases.
- To understand the mechanisms of beta-lactam antibiotic resistance mediated by PBPs.
Main Methods:
- Comparative analysis of amino acid sequences of PBPs and beta-lactamases.
- Examination of three-dimensional structural similarities between low-molecular-weight PBPs and class A beta-lactamases.
- Investigation of PBP structure and function in Escherichia coli.
- Analysis of genetic alterations in PBPs conferring resistance in Neisseria gonorrhoeae.
Main Results:
- Structural similarities support a common evolutionary origin for PBPs and beta-lactamases.
- High-molecular-weight PBPs in E. coli possess distinct transglycosylase and transpeptidase domains.
- Amino acid substitutions in the transpeptidase domain of PBPs confer resistance to beta-lactam antibiotics in N. gonorrhoeae.
Conclusions:
- PBPs and beta-lactamases share a distant evolutionary heritage, evidenced by structural and sequence data.
- Understanding PBP structure is key to developing new beta-lactam antibiotics and combating resistance.
- Alterations in PBP transpeptidase domains are a significant mechanism for bacterial resistance to beta-lactam antibiotics.